A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/16/2006	US20060258564 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060258562 Comprises insulin and serine/threonine protein kinases (PKCs) for inducing/accelerating cell proliferation/differentiation; treating diabetic ulcers
11/16/2006	US20060258561 Novel NPH insulin preparations
11/16/2006	US20060258560 Dry tissue sealant compositions
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257980 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
11/16/2006	US20060257971 Antibodies to pro1561 polypeptide
11/16/2006	US20060257970 Human HAC3
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257928 ANGE gene in atopy
11/16/2006	US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257868 Tissue specific genes and gene clusters
11/16/2006	US20060257852 Severe acute respiratory syndrome coronavirus
11/16/2006	US20060257850 Methods of treatment and diagnosis of patients with hepatitis c infection
11/16/2006	US20060257843 Kappa-PVIIA-related conotoxins as organ protectants
11/16/2006	US20060257497 Use of Tryptophan rich peptides
11/16/2006	US20060257492 Suspension of calcium phosphate particulates for local delivery of therapeutic agents
11/16/2006	US20060257488 Injectable hydrogels and methods of making and using same
11/16/2006	US20060257479 Long-acting molecules in sustained release formulations
11/16/2006	US20060257468 Dietary products comprising one or more of gamma-polyglutamic acid (gamma-PGA, H form) and gamma-polyglutamates for use as nutrition supplements
11/16/2006	US20060257449 Methods, compositions, systems, and devices for bone fusion
11/16/2006	US20060257430 Methods of modulating intracellular degradation rates of toxins
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257419 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host
11/16/2006	US20060257416 Materials and methods for improved vaccination
11/16/2006	US20060257408 Method for influencing kinase pathways with IL-22
11/16/2006	US20060257405 Diagnostics and therapeutics for diseases associated with aryl hydrocarbon receptor (ahr)
11/16/2006	US20060257404 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
11/16/2006	US20060257403 Methods for treating and preventing fibrosis
11/16/2006	US20060257402 Use of soluble cd164 in inflammatory and/or autoimmune disorders
11/16/2006	US20060257401 Sensitizing cells for apoptosis by selectively blocking cytokines
11/16/2006	US20060257391 Non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
11/16/2006	US20060257390 Catheter Composition and Uses Thereof
11/16/2006	US20060257389 Diagnosis of blood clots using fibrin-binding proteins bound with contrast agents
11/16/2006	US20060257388 Drug delivery systems for stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
11/16/2006	US20060257387 Sugar chain synthase gene
11/16/2006	US20060257386 Cosmetic composition and methods
11/16/2006	US20060257385 Dietary supplement formulations for improved delivery of coenzyme Q10 and methods of administration
11/16/2006	US20060257382 Corneal cells expressing active agents and methods of use thereof
11/16/2006	US20060257380 Use of sirnas for gene silencing in antigen presenting cells
11/16/2006	US20060257376 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function
11/16/2006	US20060257371 Adenoviral vectors for treating diseases
11/16/2006	US20060257370 Adenoviral vectors for treating diseases
11/16/2006	US20060257369 Therapeutic regimen for treating cancer
11/16/2006	US20060257367 Tumour-cell specific gene expression and its use in cancer therapy
11/16/2006	US20060257365 Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
11/16/2006	US20060257364 Materials and methods for inhibition of IgE production
11/16/2006	US20060257363 Treatment using an interferon
11/16/2006	US20060257362 Method and composition for preventing and reating solid tumors
11/16/2006	US20060257361 Novel form of interleukin-15, Fc-IL-15, and methods of use
11/16/2006	US20060257360 Protein based TNF-alpha variants for the treatment of TNF-alpha related disorders
11/16/2006	US20060257359 Modifying macrophage phenotype for treatment of disease
11/16/2006	US20060257358 Suspension of calcium phosphate particulates for local delivery of therapeutic agents
11/16/2006	US20060257357 Method for modulating HLA class II tumor cell surface expression with a cytokine mixture
11/16/2006	US20060257356 Administering EBV peptide epitope for eliciting an immune response against EBV; therapy and prophylaxis of lymphoproliferative disorders
11/16/2006	US20060257326 Methods and formulations for delivery of pharmacologically active agents
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	DE59207523C5 Prepn. of compsn. contg. human protein and pharmaceuticals for infusion - contains preservatives which are opt. removed before storage, for germ free prod. giving minimal pain upon application
11/16/2006	DE102005028295A1 New polynucleotide encoding a protease active at low temperature, for use e.g. in cleaning, pharmaceutical and cosmetic compositions and for eliminating biofilms
11/16/2006	DE102005023155A1 Albuminlösung Albumin solution
11/16/2006	CA2811995A1 Use of histones to treat thrombocytopenia
11/16/2006	CA2643736A1 Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
11/16/2006	CA2618046A1 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture
11/16/2006	CA2608315A1 Use of a new gene coding for a new member of the mcm2-8 family in pharmaceutical compositions
11/16/2006	CA2608271A1 Milk fat globule epidermal growth factor-factor viii and sepsis
11/16/2006	CA2608019A1 Use of histones to treat thrombocytopenia
11/16/2006	CA2607824A1 Hydratable keratin compositions
11/16/2006	CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	CA2607697A1 Treating and evaluating inflammatory disorders
11/16/2006	CA2607566A1 Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
11/16/2006	CA2607293A1 Use of tfpi to treat severe bacterial infections
11/16/2006	CA2607273A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
11/16/2006	CA2607267A1 Health food and pharmaceutical composition for amelioration of disease induced by metabolic disorder in cartilage
11/16/2006	CA2607181A1 A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
11/16/2006	CA2607176A1 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
11/16/2006	CA2607145A1 Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria
11/16/2006	CA2607044A1 Cardiovascular disease therapies
11/16/2006	CA2606997A1 Stabilizer molecule-depleted albumin solution
11/16/2006	CA2606939A1 Polymeric derivative of cytidine metabolic antagonist
11/16/2006	CA2606871A1 Use of native peptides and their optimized derivatives for vaccination
11/16/2006	CA2606778A1 Vascular disease therapies
11/16/2006	CA2605551A1 Compositions for administering rnaiii-inhibiting peptides
11/16/2006	CA2605006A1 Melanoma-associated endogenous retrovirus (merv) derived peptide sequences and their therapeutic/ diagnostic use
11/16/2006	CA2603873A1 Abuse-resistant amphetamine prodrugs
11/15/2006	EP1721979A1 Compositions and methods for increasing bone mineralisation
11/15/2006	EP1721978A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof
11/15/2006	EP1721971A1 Screening method
11/15/2006	EP1721909A1 Growth factor mutants with altered biological attributes
11/15/2006	EP1721617A2 Dental therapeutics containing parathyroid hormone
11/15/2006	EP1721616A1 Soothing agent and food for treating fatigue
11/15/2006	EP1721157A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions
11/15/2006	EP1721003A1 Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5)
11/15/2006	EP1720996A1 Fusion proteins containing recombinant cytotoxic rnases
11/15/2006	EP1720984A1 Methods and compositions for treatment or prevention of secondary ischemic injury
11/15/2006	EP1720911A1 Fusion protein comprising tatdmt polypeptide
11/15/2006	EP1720910A2 Method and composition for angiogenesis inhibition
11/15/2006	EP1720904A1 Treating or preventing extracellular matrix build-up

1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 3163